← back to search

Jose M. Jiménez-Guardeño

Instituto de Investigación Biomédica de Málaga · ES
Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, HIV Research and Treatment, and Animal Virus Infections Studies.
h-index
25
citations
5,876
works
53
NIH funding
primary concept
email

Recent publications

Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2
Molecular Therapy 2022cited by 29position: middledoi
Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia
Nature 2021cited by 437position: middledoi
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
Immunity 2021cited by 167position: middledoi
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Nature Microbiology 2021cited by 116position: middledoi
An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
Pathogens 2021cited by 51position: middledoi
Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation
PLoS ONE 2021cited by 40position: middledoi
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
PLoS Pathogens 2021cited by 34position: middledoi
Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans
Nature Microbiology 2020cited by 1,380position: middledoi
Immunoproteasome activation enables human TRIM5α restriction of HIV-1
Nature Microbiology 2019cited by 69position: firstdoi
The GTPase Domain of MX2 Interacts with the HIV-1 Capsid, Enabling Its Short Isoform to Moderate Antiviral Restriction
Cell Reports 2019cited by 37position: middledoi
Multiple components of the nuclear pore complex interact with the amino-terminus of MX2 to facilitate HIV-1 restriction
PLoS Pathogens 2018cited by 61position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Michael H. Malim · King's College London6 papers (2018–2022)Gilberto Betancor · Universidad de Las Palmas de Gran Canaria3 papers (2018–2019)Matthew D. J. Dicks · BrioBiotech (United States)3 papers (2018–2022)Luis Apolonia · King's College London3 papers (2018–2019)Caroline Goujon · Centre National de la Recherche Scientifique2 papers (2018–2021)Carl Graham · King's College London2 papers (2021–2022)Ana Maria Ortega‐Prieto · Hospital Regional Universitario de Málaga2 papers (2021–2021)Katie J. Doores · King's College London2 papers (2021–2022)Simon J. Draper · Centre for Human Genetics1 papers (2022–2022)Lucie Pessel-Vivares · Centre National de la Recherche Scientifique1 papers (2018–2018)Antonio Cannatà · British Heart Foundation1 papers (2021–2021)Luca Braga · King's College London1 papers (2021–2021) · 1 papers (2022–2022)Edoardo Schneider · International Centre for Genetic Engineering and Biotechnology1 papers (2021–2021)Juan Burrone · King's College London1 papers (2021–2021) · 1 papers (2021–2021)Hashim Ali · King's College London1 papers (2021–2021)Andrew D. Davidson · Max Planck-Bristol Centre for Minimal Biology1 papers (2021–2021) · 1 papers (2021–2021)Ajay M. Shah · Abasyn University1 papers (2021–2021)